DG

Daniil Gataulin Chardan Capital Latest Price Targets & Analyst Ratings

Main Sector
Healthcare
Ratings Past Year
77
Avg Return
Past Year
17%
Success Rate
Past Year
0 %
Rating Distribution Past Year
Positive 90.1%
Neutral 9.9%
Negative 0%
Stock Rating Price Target Upside
Downside 		Ratings
1 Year 		Avg Return
1 Year 		Success Rate
1 Year 		Date
Buy Initiated
$9
357%
upside
1 -1.5%
0 %
16 Oct ‘25 4 days ago
Buy Maintained
$51
134%
upside
5 +4.3%
0 %
8 Oct ‘25 12 days ago
Neutral Maintained
$14
17%
downside
1 –
–
6 Oct ‘25 14 days ago
Buy Maintained
$21
74%
upside
2 -2.2%
0 %
2 Oct ‘25 18 days ago
Buy Maintained
$10
187%
upside
2 +42%
0 %
30 Sep ‘25 20 days ago
Buy Maintained
$76
21%
upside
8 +33%
0 %
25 Sep ‘25 25 days ago
Buy Maintained
$7
329%
upside
9 +7.1%
0 %
19 Sep ‘25 1 month ago
Neutral Downgraded
$48
0%
upside
4 +48%
0 %
10 Sep ‘25 1 month ago
Buy Maintained
$52
314%
upside
7 +5.3%
0 %
8 Sep ‘25 1 month ago
Neutral Maintained
$3
108%
upside
4 –
–
28 Aug ‘25 1 month ago
Buy Maintained
$61
418%
upside
5 +63%
0 %
15 Aug ‘25 2 months ago
Buy Maintained
$35
326%
upside
4 +11%
0 %
15 Aug ‘25 2 months ago
Buy Maintained
$33
633%
upside
3 +23%
0 %
13 Aug ‘25 2 months ago
Buy Maintained
$15
104%
upside
6 -9.8%
0 %
11 Aug ‘25 2 months ago
Buy Maintained
$4
115%
upside
7 +33%
0 %
8 Aug ‘25 2 months ago
Buy Maintained
$27
128%
upside
6 +4.2%
0 %
7 Aug ‘25 2 months ago
Neutral Downgraded
– – 3 -22%
0 %
18 Jul ‘25 3 months ago